News & Blog

Tag Archives: pharmaceutical companies

Can Army Cadets from West Point Help Pediatric Brain Tumor Treatments Get to Market?

During a mid-March scientific and policy meeting, a group of cadets from the United States Military Academy at West Point – none biology or pre-med majors – stood before a group of leading international pediatric cancer researchers, representatives from major biopharmaceutical companies, and officials from government agencies like the National Cancer Institute, U.S. Food and [...]

Project Impact Gets to Work: Removing Barriers to Pediatric Cancer Treatments

The choice of when to push change in a broken system, “depends largely on timing, opportunity, and the leverage of the people initiating the change,[1]” according to popular theories in system change. Moreover, to achieve systems change leaders must, “bring people addressing parts of the problem around the same table,” and by “…inviting new people [...]

Introducing the Jumpstarting Brain Tumor Drug Development Coalition

We first told you about our Clinical Trial Endpoints Initiative back in late June of 2013. We then let the Chair of the Initiative’s Steering Committee, Dr. Patrick Wen of Dana-Farber Cancer Institute, explain the promise of this effort further in a video interview we posted back in December. Now, we’d like to introduce you [...]

Share